Suppr超能文献

KAI1是一种新的转移抑制基因,在转移性肝细胞癌中表达降低。

KAI1, a new metastasis suppressor gene, is reduced in metastatic hepatocellular carcinoma.

作者信息

Guo X Z, Friess H, Di Mola F F, Heinicke J M, Abou-Shady M, Graber H U, Baer H U, Zimmermann A, Korc M, Büchler M W

机构信息

Department of Visceral and Transplantation Surgery, University of Bern, Inselspital, Bern, Switzerland.

出版信息

Hepatology. 1998 Dec;28(6):1481-8. doi: 10.1002/hep.510280606.

Abstract

Down-regulation of KAI1 expression has been shown to be associated with formation of metastases or disease progression in prostate and pancreatic cancer. In the present study we analyzed the expression pattern of KAI1 in metastatic and nonmetastatic hepatocellular carcinomas (HCCs) in comparison with normal livers to evaluate whether alteration of KAI1 also facilitates the metastatic ability in this malignancy. Thirty-nine primary HCCs and 10 normal liver tissue samples were studied for KAI1 messenger RNA (mRNA) expression with use of Northern blot analysis and in situ hybridization. By Northern blot analysis, moderate to strong KAI1 mRNA expression was present in normal liver samples. In contrast, KAI1 mRNA expression in tissue samples of primary HCCs was markedly decreased compared with normal controls. The normal/tumor ratio of KAI1 mRNA expression was 2.6:1 (P <.01). Primary HCCs that gave rise to metastasis showed significantly lower KAI1 mRNA levels than nonmetastasized HCCs (P <. 05). As seen by in situ hybridization, moderate to strong cytoplasmic KAI1 mRNA staining was present in almost all normal hepatocytes. Bile ducts, blood vessels, and connective tissue showed no or only faint KAI1 mRNA expression in the normal liver samples. In nonmetastatic HCCs, the cancer cells exhibited in situ hybridization signals that were similar to the normal controls. In contrast, most of the primary HCC cells in samples with metastases showed only faint or moderate KAI1 mRNA expression predominantly in the perinuclear regions. When KAI1 mRNA expression of primary hepatocellular cancer cells was compared with metastasized cancer cells in lymph nodes, with intrahepatic satellite metastasis, or with peritoneal metastasis in the same patients, significantly lower (P <.01) KAI1 mRNA levels were present in the metastasized HCC cells. Reduced KAI1 mRNA in HCC cells seems to influence their metastatic ability and thereby enhances the malignant potential of HCC.

摘要

KAI1表达下调已被证明与前列腺癌和胰腺癌的转移形成或疾病进展相关。在本研究中,我们分析了KAI1在转移性和非转移性肝细胞癌(HCC)中的表达模式,并与正常肝脏进行比较,以评估KAI1的改变是否也促进了这种恶性肿瘤的转移能力。使用Northern印迹分析和原位杂交技术,对39例原发性HCC和10例正常肝组织样本进行了KAI1信使核糖核酸(mRNA)表达研究。通过Northern印迹分析,正常肝脏样本中存在中度至强的KAI1 mRNA表达。相比之下,原发性HCC组织样本中的KAI1 mRNA表达与正常对照相比明显降低。KAI1 mRNA表达的正常/肿瘤比值为2.6:1(P<.01)。发生转移的原发性HCC显示出的KAI1 mRNA水平明显低于未转移的HCC(P<.05)。原位杂交显示,几乎所有正常肝细胞中都存在中度至强的细胞质KAI1 mRNA染色。正常肝脏样本中的胆管、血管和结缔组织未显示或仅显示微弱的KAI1 mRNA表达。在非转移性HCC中,癌细胞表现出与正常对照相似的原位杂交信号。相比之下,有转移的样本中的大多数原发性HCC细胞仅在核周区域显示微弱或中度的KAI1 mRNA表达。当将原发性肝细胞癌细胞的KAI1 mRNA表达与同一患者淋巴结中的转移癌细胞、肝内卫星转移或腹膜转移进行比较时,转移的HCC细胞中KAI1 mRNA水平明显较低(P<.01)。HCC细胞中KAI1 mRNA的减少似乎影响了它们的转移能力,从而增强了HCC的恶性潜能。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验